Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London.
Lancet 341 (8856): 1293-8, 1993.[PUBMED Abstract] Schmid P, Untch M, Koss√© V, et al.: Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
J Clin Oncol 25 (18): 2509-15, 2007.[PUBMED Abstract] Ejlertsen B, Mouridsen HT, Jensen MB, et al.: Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.